Latest Business Trends and Insights

Business Innovation

Syngoi Technologies and Ribbon Bio commence strategic collaboration to advance Gene Therapies with Synthetic DNA

Syngoi Technologies and Ribbon Bio commence strategic collaboration to advance Gene Therapies with Synthetic DNA…

jomartinez@increnta.comMarch 11, 2025

Business Innovation Investment

Syngoi welcomes Buenavista Equity Partners after the launch of BV Healthcare Growth Innvierte I fund

Syngoi welcomes Buenavista Equity Partners after the launch of BV Healthcare Growth Innvierte I fund…

jomartinez@increnta.comDecember 12, 2024

Business Innovation Investment

CEPI partners with Afrigen to accelerate development and access to mRNA vaccine

CEPI partners with Afrigen to accelerate development and access to mRNA vaccine CEPI and…

jomartinez@increnta.comSeptember 9, 2024

Business Innovation Investment

Syngoi Technologies Expands Synthetic DNA Manufacturing Capacity Following Series B Investment Led by Columbus Venture Partners

Syngoi Technologies Expands DNA Manufacturing Capacity After Series B Investment. Syngoi's funding round enables…

guessJune 10, 2024

Business Innovation

3i Plan for the promotion of innovation and advanced investment at Bizkaia

3i Plan for the promotion of innovation and advanced investment at Bizkaia This project has…

guessOctober 19, 2023

Business Innovation

2i Plan for the promotion of innovation and advanced investment at Bizkaia

2i Plan for the promotion of innovation and advanced investment at Bizkaia This project has…

guessJuly 27, 2023

Business

Syngoi inaugurates its new facilities in Bizkaia (Spain)

The biotechnology company Syngoi inaugurates its new facilities in the Science and Technology Park of…

guessApril 19, 2023

Business

Syngoi Technologies and Ribbon Bio commence strategic collaboration to advance Gene Therapies with Synthetic DNA

Syngoi welcomes Buenavista Equity Partners after the launch of BV Healthcare Growth Innvierte I fund

CEPI partners with Afrigen to accelerate development and access to mRNA vaccine

Syngoi Technologies Expands Synthetic DNA Manufacturing Capacity Following Series B Investment Led by Columbus Venture Partners

3i Plan for the promotion of innovation and advanced investment at Bizkaia

2i Plan for the promotion of innovation and advanced investment at Bizkaia

Syngoi inaugurates its new facilities in Bizkaia (Spain)

Recent Posts

Recent Comments

Popular Posts

Categories

Visit us at

Parque Científico y Tecnológico de Bizkaia.
Ibaizabal Bidea, 501B 48170 Zamudio

Contact

info@syngoi.com

+ 34 946 09 63 09

Leading DNA Next Generation
Pure Synthetic DNA

Business

Recent Posts

Recent Comments

Popular Posts

Categories

Visit us at

Parque Científico y Tecnológico de Bizkaia. Ibaizabal Bidea, 501B 48170 Zamudio

Contact

Leading DNA Next Generation Pure Synthetic DNA

Parque Científico y Tecnológico de Bizkaia.
Ibaizabal Bidea, 501B 48170 Zamudio

Leading DNA Next Generation
Pure Synthetic DNA